Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, Gazyva, and Xeloda; osteoporosis, including Actemra, Edirol, and Bonviva; renal diseases consist of Mircera and Oxarol; and neurology/other diseases comprise Hemlibra, CellCept, and Enspryng. It has various development product candidates in the areas of oncology, bone and joint diseases, autoimmune diseases, renal diseases, neurology, and other diseases. Chugai Pharmaceutical Co., Ltd. has strategic alliances with Roche Group; and collaboration and joint research with academia. The company was founded in 1925 and is headquartered in Tokyo, Japan. Chugai Pharmaceutical Co., Ltd. is a subsidiary of Roche Holding Ltd.
Chugai Pharmaceutical Dividend Announcement
• Chugai Pharmaceutical announced a semi annually dividend of $0.12 per ordinary share which will be made payable on 2024-04-01. Ex dividend date: 2023-12-28
• Chugai Pharmaceutical annual dividend for 2023 was $0.22
• Chugai Pharmaceutical's trailing twelve-month (TTM) dividend yield is 0.51%
• Chugai Pharmaceutical's payout ratio for the trailing twelve months (TTM) is 36.97%
Chugai Pharmaceutical Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2023-12-28 | $0.12 | semi annually | 2024-04-01 |
2023-06-29 | $0.10 | semi annually | 2023-09-14 |
2022-12-29 | $0.11 | semi annually | 2023-04-14 |
2022-06-28 | $0.11 | semi annually | 2022-09-14 |
Chugai Pharmaceutical Dividend per year
Chugai Pharmaceutical Dividend Yield
Chugai Pharmaceutical current trailing twelve-month (TTM) dividend yield is 0.51%. Interested in purchasing Chugai Pharmaceutical stock? Use our calculator to estimate your expected dividend yield:
Chugai Pharmaceutical Financial Ratios
Chugai Pharmaceutical Dividend FAQ
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Place an order: Use the brokerage's trading platform to place an order to buy Chugai Pharmaceutical stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.